Find a Clinical Trial
Filter
Collagen Urine Assay
Male
50-80
Recruiting now
Department of Urology
Tufts Medical Center
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Tufts Medical Center
LYS228 Pharmacokinetics for Complicated UTI
Urinary tract infections
All genders
18-85
Recruiting now
Department of Urology
Tufts Medical Center
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
18-90
Recruiting now
Department of Urology
Tufts Medical Center
VAPOR 2
Prostate cancer
All genders
50-89
Recruiting now
Department of Urology
Tufts Medical Center